Enbrel Launch Budget Will Be $100 Mil.; Patient Testimonials Planned
Executive Summary
Immunex and AHP plan to invest $100 mil. in the launch of the rheumatoid arthritis therapy Enbrel, Immunex CEO Edward Fritzky told the CIBC Oppenheimer Health Care Conference in New York City Oct. 28.